Wallwiener, Markus Nabieva, Naiba Feisst, Manuel Fehm, Tanja Waal, Johann Rezai, Mahdi Baier, Bernd Baake, Gerold Kolberg, Hans-Christian Guggenberger, Martin Warm, Mathias Harbeck, Nadia Wuerstlein, Rachel Deuker, JĂśrg-Uwe Dall, Peter Richter, Barbara Wachsmann, Grischa Brucker, Cosima Siebers, Jan Popovic, Milos Kuhn, Thomas Wolf, Christopher Vollert, Hans-Walter Breitbach, Georg-Peter Janni, Wolfgang Landthaler, Robert Kohls, Andreas Rezek, Daniela Noesselt, Thomas Fischer, Gunnar Henschen, Stephan Praetz, Thomas Heyl, Volker KĂźhn, Thorsten Krauss, Thomas Thomssen, Christoph Hohn, Andre Tesch, Hans Mundhenke, Christoph Hein, Alexander Rauh, Claudia Bayer, Christian Schmidt, Katja Belleville, Erik Brucker, Sara Hadji, Peyman Beckmann, Matthias Wallwiener, Diethelm KĂźmmel, Sherko Hartkopf, Andreas Fasching, Peter Additional file 1: of Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study Figure S1. Patient flow chart (DOCX 93 kb) Advanced/metastatic breast cancer;Palliative/metastatic treatment;Compliance;Persistence;Endocrine treatment/therapy;Aromatase inhibitor 2019-06-21
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Influence_of_patient_and_tumor_characteristics_on_therapy_persistence_with_letrozole_in_postmenopausal_women_with_advanced_breast_cancer_results_of_the_prospective_observational_EvAluate-TM_study/8310614
10.6084/m9.figshare.8310614.v1